The International Agency for Research on Cancer (IARC) has released a new IARC Evidence Summary Brief, titled “Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy”. This report highlights promising recent developments, led by scientists from IARC and partners, that are huge steps to accelerate the elimination of cervical cancer as a threat to global public health.
This IARC Evidence Summary Brief is the fourth in a series of scientific Evidence Summary Briefs published by IARC to call attention to the findings of evidence-based studies in key aspects of cancer prevention.
Press releaseIARC Press Release 333
Download PDFProtection from a Single Dose of HPV Vaccine
Protection from a Single Dose of HPV Vaccine
A major public health impact from IARC studies of vaccine efficacy, IARC Evidence Summary Brief No. 4
Download PDF: English, FrenchEvidence Summary Briefs series